홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1S)- → 1-[1-(8,9-dimethyl-9H-purin-6-yl)piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one

HRID 528030
인쇄

반응식

HRID 528030 반응식
[NH2:1][C:2]1[C:3]([N:10]2[CH2:15][CH2:14][CH:13]([N:16]3C4C=CC=CC=4[NH:18][C:17]3=[O:25])[CH2:12][CH2:11]2)=[N:4][CH:5]=[N:6][C:7]=1[NH:8][CH3:9].[C:26]12(CS(O)(=O)=O)C(C)(C)[CH:30]([CH2:31][CH2:32]1)[CH2:29][C:27]2=O.[CH3:41][C:42](C)(C)C([O-])([O-])[O-]>C(#N)C>[CH3:41][C:42]1[N:8]([CH3:9])[C:7]2[C:2]([N:1]=1)=[C:3]([N:10]1[CH2:11][CH2:12][CH:13]([N:16]3[C:27]4[CH:29]=[CH:30][CH:31]=[CH:32][C:26]=4[NH:18][C:17]3=[O:25])[CH2:14][CH2:15]1)[N:4]=[CH:5][N:6]=2
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 18462Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1S)-HCID 21927715TrimethylorthoacetateHCID 668022691-(1-(5-amino-6-(methylamino)pyrimidin-4-yl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one

생성물 1

HCID 668017311-[1-(8,9-dimethyl-9H-purin-6-yl)piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one수율 385%

시약·촉매·용매 1

HCID 6342
Acetonitrile
용매

실험 절차

To 1-{1-[5-amino-6-(methylamino)pyrimidin-4-yl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one (150 mg, 0.442 mmol) in acetonitrile (2 mL) was added camphorsulfonic acid (4.9 mg, 0.02 mmol) and trimethylorthoacetate (2 mL, 16.6 mmol). The mixture was heated at reflux for 15 h, then was cooled to ambient and was purified by preparative-HPLC to afford 1-[1-(8,9-dimethyl-9H-purin-6-yl)piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one as a beige solid (28 mg, 0.077 mmol, 17% yield).

후처리

  1. temperatureThe mixture was heated
  2. temperatureat reflux for 15 h
  3. temperaturewas cooled to ambient and
  4. customwas purified by preparative-HPLC

출처 및 근거

ORD 기록
ord-a7bb55dee08a4083a18b32277d3d07d8
출처 데이터셋
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09346807B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트